These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12030947)

  • 1. Peptic ulceration in general practice in England and Wales 1994-98: period prevalence and drug management.
    Kang JY; Tinto A; Higham J; Majeed A
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1067-74. PubMed ID: 12030947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the NIH Consensus Conference on Helicobacter pylori on physician prescribing among a Medicaid population.
    Thamer M; Ray NF; Henderson SC; Rinehart CS; Sherman CR; Ferguson JH
    Med Care; 1998 May; 36(5):646-60. PubMed ID: 9596056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age, sex and practice variations in the use of statins in general practice in England and Wales.
    Majeed A; Moser K; Maxwell R
    J Public Health Med; 2000 Sep; 22(3):275-9. PubMed ID: 11077897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends in the incidence of peptic ulcers and oesophagitis between 1994 and 2003.
    Bartholomeeusen S; Vandenbroucke J; Truyers C; Buntinx F
    Br J Gen Pract; 2007 Jun; 57(539):497-9. PubMed ID: 17550678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review: the global incidence and prevalence of peptic ulcer disease.
    Sung JJ; Kuipers EJ; El-Serag HB
    Aliment Pharmacol Ther; 2009 May; 29(9):938-46. PubMed ID: 19220208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects.
    Higham J; Kang JY; Majeed A
    Gut; 2002 Apr; 50(4):460-4. PubMed ID: 11889062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription patterns of traditional Chinese medicine for peptic ulcer disease in Taiwan: A nationwide population-based study.
    Huang CY; Lai WY; Sun MF; Lin CC; Chen BC; Lin HJ; Chang CM; Yang CH; Huang KC; Yen HR
    J Ethnopharmacol; 2015 Dec; 176():311-20. PubMed ID: 26549268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is antisecretory therapy after pancreatoduodenectomy necessary? Meta-analysis and contemporary practices of pancreatic surgeons.
    Butler JR; Rogers T; Eckart G; Martens GR; Ceppa EP; House MG; Nakeeb A; Schmidt CM; Zyromski NJ
    J Gastrointest Surg; 2015 Apr; 19(4):604-12. PubMed ID: 25691111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits.
    O'Connor HJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):487-96. PubMed ID: 11876702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice?
    Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
    Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time, change and peptic ulcer disease in Rotherham, UK.
    Bardhan KD; Royston C
    Dig Liver Dis; 2008 Jul; 40(7):540-6. PubMed ID: 18407812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002.
    Kang JY; Elders A; Majeed A; Maxwell JD; Bardhan KD
    Aliment Pharmacol Ther; 2006 Jul; 24(1):65-79. PubMed ID: 16803604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroduodenal Ulceration in Small Animals: Part 2. Proton Pump Inhibitors and Histamine-2 Receptor Antagonists.
    Daure E; Ross L; Webster CR
    J Am Anim Hosp Assoc; 2017; 53(1):11-23. PubMed ID: 27841679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of prescriptions for peptic ulcer drugs (ACT class AOB2) in Iceland.
    Thors H; Sigurdsson H; Oddsson E; Thjodleifsson B
    Scand J Gastroenterol; 1994 Nov; 29(11):988-94. PubMed ID: 7871379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inequalities in treated heart disease and mental illness in England and Wales, 1994-1998.
    Moser K
    Br J Gen Pract; 2001 Jun; 51(467):438-44. PubMed ID: 11407047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2001 Jul; 15(7):917-26. PubMed ID: 11421865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication ameliorates symptoms and improves quality of life in patients on long-term acid suppression. A large prospective study in primary care.
    Verma S; Giaffer MH
    Dig Dis Sci; 2002 Jul; 47(7):1567-74. PubMed ID: 12141818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in morbidity and mortality from peptic ulcer disease: Tayside versus Scotland.
    Penston JG; Crombie IK; Waugh NR; Wormsley KG
    Aliment Pharmacol Ther; 1993 Aug; 7(4):429-42. PubMed ID: 8105985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks versus benefits of long-term proton pump inhibitor therapy in the elderly.
    Schuler A
    Geriatr Nurs; 2007; 28(4):225-9. PubMed ID: 17936957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.